Inhibition of angiogenesis as a strategy for tumor growth control
- 37 Downloads
Angiogenesis is a complex sequence of events leading to the formation of new capillaries. Although essential to maturation and wound healing, most angiogenesis in the adult is associated with pathological events, such as the development of solid tumors. One approach to the inhibition of angiogenesis is the antagonism of basic fibroblast growth factor, a major angiogenic protein. Evidence is reviewed to suggest that inhibiting angiogenesis results in the suppression of tumor growth.
Index EntriesAngiogenesis tumor growth capillaries vascularization endothelial cells basic fibroblast growth factor gliomas melanomas suramin platelet factor 4 minocycline thrombospondin fumagillin laminin herbimycin A d-penicillamine
Unable to display preview. Download preview PDF.
- Folkman J. L. (1990b) The angiogenic activity of FGF and its possible clinical applications, inGrowth Factors: from Genes to Clinical Application (Sara, V. R., et al., eds.), Raven, New York.Google Scholar
- Gross J. L., Hertel D., Herblin W. F., Neville M. and Brem S. S. (1991) Inhibition of basic fibroblast growth factor-induced angiogenesis and glioma tumor growth in vivo in copper depleted rats.Proc. Amer. Assoc. Cancer Res. 32, 57.Google Scholar
- Gross J. L., Herblin W. F., Eidsvoog K., Horlick R., and Brem S. S. (in press) Tumor growth regulation by modulation of basic fibroblast growth factor, inAngiogenesis, (Steiner R. and Langer R., eds.), Karger, Basel.Google Scholar
- Herblin W. F. and Gross J. L. (in press) High affinity sites for basic fibroblast growth factor in solid tumors are associated with the vasculature, inAngiogenesis, (Steiner R. and Langer, R., eds.) Karger, Basel.Google Scholar